SEC Form 3 · accession 0001144204-18-054565
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Juan Vera
Director
Period of report
Oct 17, 2018
Accepted (ET)
Oct 19, 2018 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,993,059 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants to Acquire Common Stock | $2.99 | holding | — | — | — | Oct 17, 2018 | Oct 17, 2023 | Common Stock | 722,783 | — | D |
Remarks
* Mr. Mark A. Catchur is signing as Attorney-in-Fact pursuant to power of attorney dated October 5, 2018 granted by each Reporting Person, a copy of which is filed as an exhibit and incorporated herein by reference.